Offer - Urjas Oil for just ₹ 1 X
Olmetrack H 12.5 Mg/20 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Olmetrack H 12.5 Mg/20 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Olmetrack H 12.5 Mg/20 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Olmetrack H 12.5 Mg/20 Mg Tablet also has some side effects, the most common being Upper respiratory tract infection. Some other side effects of Olmetrack H 12.5 Mg/20 Mg Tablet have been listed ahead. Such side effects of Olmetrack H 12.5 Mg/20 Mg Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olmetrack H 12.5 Mg/20 Mg Tablet is Severe for pregnant women and Mild for women who are breastfeeding. In addition, Olmetrack H 12.5 Mg/20 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Olmetrack H 12.5 Mg/20 Mg Tablet related warnings section.
Olmetrack H 12.5 Mg/20 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olmetrack H 12.5 Mg/20 Mg Tablet in conditions like Asthma, Allergy, Kidney Disease. Other conditions have been mentioned below in the Olmetrack H 12.5 Mg/20 Mg Tablet contraindications section.
Additionally, Olmetrack H 12.5 Mg/20 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Olmetrack H 12.5 Mg/20 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmetrack H 12.5 Mg/20 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmetrack H 12.5 Mg/20 Mg Tablet safe for pregnant women?
Olmetrack H shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmetrack H 12.5 Mg/20 Mg Tablet safe during breastfeeding?
Breastfeeding women can take Olmetrack H as it bears very minor side effects for them.
What is the effect of Olmetrack H 12.5 Mg/20 Mg Tablet on the Kidneys?
Olmetrack H rarely affects the kidneys.
What is the effect of Olmetrack H 12.5 Mg/20 Mg Tablet on the Liver?
Very few cases of side effects of Olmetrack H on the liver have been reported.
What is the effect of Olmetrack H 12.5 Mg/20 Mg Tablet on the Heart?
Side effects of Olmetrack H rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Olmetrack H 12.5 Mg/20 Mg Tablet unless your doctor advises you to do so -
Is this Olmetrack H 12.5 Mg/20 Mg Tablet habit forming or addictive?
Forming a habit of Olmetrack H 12.5 Mg/20 Mg Tablet has not been reported.
Interaction between Food and Olmetrack H 12.5 Mg/20 Mg Tablet
Olmetrack H 12.5 Mg/20 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmetrack H 12.5 Mg/20 Mg Tablet
Consult your doctor before consuming alcohol while taking Olmetrack H 12.5 Mg/20 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173